Establishing a mouse model of disease to test combined antisense oligonucleotides and AAV systemic gene therapy as new treatment for Oculopharyngeal muscular dystrophy

Project: Research

StatusActive
Effective start/end date1/09/2131/08/22

Funding

AFM Telethon: £40,323

ID: 43365374